arrow
F

F. David Fortuin

Mayo Clinic
H指数:22
被引数:3,597

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes

心肌梗死后2型糖尿病患者早期胰高血糖素样肽-1受体激动剂的使用

2025-11-240
PRE
Association between echocardiographic velocity time integral ratio of mitral valve and left ventricular outflow tract and clinical outcomes post transcatheter edge-to-edge mitral valve repair
HELIYON
IF3.6
2024-06-011
OAAI
The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
2024-03-134
OAAI
Artificial Intelligence Applied to the Electrocardiogram Predicts Outcomes in Patients With Severe Aortic Stenosis and Potential Cardiac Amyloidosis Undergoing Transcatheter Aortic Valve Replacement

人工智能在重度主动脉瓣狭窄和潜在心脏淀粉样变患者经导管主动脉瓣置换术中的应用

2023-11-070
PRE
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials

自体CD34细胞疗法可改善无可选性难治性心绞痛的运动能力,心绞痛频率并降低死亡率: 对随机双盲试验的患者水平汇总分析

2018-01-0575
OAAI
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study
2016-09-0155
OAAI
The RENEW Trial Efficacy and Safety of Intramyocardial Autologous CD34+ cell Administration in Patients With Refractory Angina

难治性心绞痛患者心肌内自体CD34细胞给药的有效性和安全性的RENEW试验

2016-08-01103
OAAI